Argyle Capital Partners »

SPDR S&P Biotech shares owned by Argyle Capital Partners

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Argyle Capital Partners from 13F filings

Historical chart of Argyle Capital Partners investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Argyle Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Argyle Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 24k 100.20
2025-06-30 $2.1M 26k 82.93
2025-03-31 $2.2M 27k 81.10
2024-12-31 $2.0M 22k 90.06

More positions owned by Argyle Capital Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust S&p Biotech (XBI)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Jpmorgan Chase Finl Cal Lkd 44 (AMJB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Argyle Capital Partners

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board
Leucadia National Corporation

View all funds holding SPDR S&P Biotech